神经成像和病理学生物标志物在帕金森病和帕金森症
Roberto Cilia1, Dario Arnaldi2,3, Bénédicte Ballanger4
1Fondazione IRCCS Istituto Neurologico Carlo Besta, Department of Clinical Neurosciences, Parkinson and Movement Disorders Unit, 20133 Milano, Italy.
Brain sciences
|January 28, 2026
概括
最先进的神经成像和病理学生物标志物对于帕金森病的诊断,分层和临床试验至关重要. 协调和验证是推动生物标志物在研究和实践中的资格的关键.
科学领域:
- 神经科学是一个神经科学.
- 神经学 神经学
- 生物标志物研究 生物标志物研究
背景情况:
- 帕金森病 (PD) 的诊断和管理依赖于确定可靠的生物标志物.
- 神经成像和分子病理学的进步为了解PD提供了新的途径.
- 在米兰的一个课程强调了PD生物标志物的最新发展.
研究的目的:
- 综合了来自神经成像和帕金森病病理学生物标志物课程的关键发现.
- 突出诊断,患者分层和临床试验设计的融合信息.
- 强调生物标志物协调和验证的重要性.
主要方法:
- 通过神经递质功能障碍,蛋白质病理学和临床翻译对最先进的生物标志物的审查.
- 讨论神经成像技术,包括正子发射断层扫描 (PET),单光子发射计算机断层扫描 (SPECT) 和磁共振成像 (MRI).
- 探索分子病理标志物,种子放大试验和皮肤活检.
主要成果:
- 神经成像 (PET,SPECT,MRI) 提供了对神经递质缺陷 (多巴胺,诺亚胺等) 的见解. ) 的情况.
- 蛋白质病理 (α-synuclein,tau,amyloid) 的体内成像显示出预后相关性.
- 生物标志物为个性化管理策略提供信息,包括深度大脑刺激.
结论:
- 多模式生物标志物对于帕金森病的个性化管理至关重要.
- 协调,纵向验证和病理确认对于生物标志物的发展至关重要.
- 这些生物标志物将推动PD多中心研究和临床实践的进展.
相关概念视频
01:37Neural Regulation
Digestion begins with a cephalic phase that prepares the digestive system to receive food. When our brain processes visual or olfactory information about food, it triggers impulses in the cranial nerves innervating the salivary glands and stomach to prepare for food.
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:23Alzheimer Disease ll: Pathophysiology
Alzheimer disease involves structural changes in the brain that begin long before symptoms appear. The most distinctive features are extracellular neuritic plaques and intracellular neurofibrillary tangles.Neuritic plaques form in the cerebral cortex and around blood vessels. These plaques contain a dense core of beta-amyloid (Aβ)—a toxic protein fragment that clumps outside neurons. The core is surrounded by damaged neuronal extensions, as well as reactive astrocytes and microglia. Abnormal...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...